Didanosine reduces atevirdine absorption in subjects with human immunodeficiency virus infections.

Atevirdine is a nonnucleoside reverse transcriptase inhibitor with in vitro activity against human immunodeficiency virus type 1 and is currently in phase II clinical trials. Atevirdine is most soluble at a pH of < 2, and therefore, normal gastric acidity is most likely necessary for optimal bioa...

Full description

Saved in:
Bibliographic Details
Main Authors: Morse, G D, Fischl, M A, Shelton, M J, Borin, M T, Driver, M R, DeRemer, M, Lee, K, Wajszczuk, C P
Format: Artigo
Language:Inglês
Published: 1996
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC163195/
https://ncbi.nlm.nih.gov/pubmed/8851608
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items